Production (Stage)
Lisata Therapeutics, Inc.
LSTA
$2.69
$0.041.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.47% | 6.49% | 2.26% | 6.61% | -0.67% |
| Total Depreciation and Amortization | 4.88% | -2.38% | -6.67% | -2.17% | -2.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.05% | 109.02% | 155.77% | -74.13% | 81.08% |
| Change in Net Operating Assets | -134.95% | -124.48% | 642.27% | 81.29% | -301.95% |
| Cash from Operations | -19.30% | -79.83% | 52.34% | 24.82% | -72.70% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 580.99% | 122.03% | -153.83% | 81.99% | 212.64% |
| Cash from Investing | 578.98% | 122.03% | -153.83% | 81.99% | 212.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 511.11% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -84.09% | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 76.04% | -- | -100.00% | 122.54% | -691.67% |
| Foreign Exchange rate Adjustments | 103.08% | -266.67% | 50.00% | 147.27% | 27.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 221.45% | 62.43% | -235.39% | 923.35% | 91.99% |